MedTrace secures U.S. patent for new heart diagnostics software
MedTrace Pharma seeks to make PET with oxygen-15 labeled water widely available in clinical settings for heart diagnostics.
Source: massdevice.com
Stay updated with breaking news from Medtrace Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MedTrace Pharma seeks to make PET with oxygen-15 labeled water widely available in clinical settings for heart diagnostics.
After selling its Plymouth campus, Prudential makes the move to the urban core of Minneapolis, giving downtown a boost.
MedTrace Pharma announced the first person scanned in a Phase 3 clinical trial, further testing its tech to bring 15 O-water to imaging.